Fortress Biotech, Inc.
Hedge Funds Holdings
Last updated:
Fortress Biotech, Inc.‘s stocks are currently a part of 35 hedge funds’ portfolios, which represents 12.34% of the total amount of its stocks outstanding. This makes up a total of 10.96M shares of Fortress Biotech, Inc.. Compared to the previous quarter, the number fell by -60.11% or -16.53M shares fewer. As for the holding position changes, 31.43% (11) of current hedge fund investors increased the number of shares held, 11.43% (4) of current holders sold a part of the shares held, and 8.57% (3) closed the holdings completely. 6 hedge funds are new holders of Fortress Biotech, Inc. stock in Q1 2023, it is 17.14% of total holders.
Hedge funds holding Fortress Biotech (Q2 2018 – Q1 2023)
| Q2 2018 | 63 |
|---|---|
| Q3 2018 | 64 |
| Q4 2018 | 56 |
| Q1 2019 | 48 |
| Q2 2019 | 48 |
| Q3 2019 | 50 |
| Q4 2019 | 54 |
| Q1 2020 | 56 |
| Q2 2020 | 73 |
| Q3 2020 | 76 |
| Q4 2020 | 85 |
| Q1 2021 | 82 |
| Q2 2021 | 81 |
| Q3 2021 | 77 |
| Q4 2021 | 80 |
| Q1 2022 | 76 |
| Q2 2022 | 61 |
| Q3 2022 | 58 |
| Q4 2022 | 49 |
| Q1 2023 | 35 |
Hedge funds changes in Fortress Biotech positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 27 | 13 | 8 | 6 |
|---|---|---|---|---|---|
| Q3 2018 | 10 | 21 | 13 | 10 | 10 |
| Q4 2018 | 5 | 17 | 16 | 13 | 5 |
| Q1 2019 | 6 | 13 | 14 | 13 | 2 |
| Q2 2019 | 15 | 7 | 12 | 15 | -1 |
| Q3 2019 | 13 | 11 | 14 | 10 | 2 |
| Q4 2019 | 12 | 14 | 11 | 7 | 10 |
| Q1 2020 | 12 | 19 | 9 | 9 | 7 |
| Q2 2020 | 29 | 21 | 5 | 11 | 7 |
| Q3 2020 | 13 | 30 | 14 | 10 | 9 |
| Q4 2020 | 18 | 29 | 22 | 9 | 7 |
| Q1 2021 | 6 | 27 | 27 | 9 | 13 |
| Q2 2021 | 10 | 26 | 29 | 11 | 5 |
| Q3 2021 | 10 | 28 | 21 | 14 | 4 |
| Q4 2021 | 14 | 28 | 23 | 10 | 5 |
| Q1 2022 | 8 | 23 | 27 | 11 | 7 |
| Q2 2022 | 15 | 15 | 21 | 28 | -18 |
| Q3 2022 | 4 | 19 | 16 | 9 | 10 |
| Q4 2022 | 7 | 8 | 14 | 11 | 9 |
| Q1 2023 | 6 | 11 | 4 | 3 | 11 |
Hedge funds changes in Fortress Biotech stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 45,000 | 26,000 |
|---|---|---|
| Q3 2018 | 0 | 31,000 |
| Q4 2018 | 0 | 1,000 |
| Q1 2019 | 0 | 25,000 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 1,164,000 | 595,000 |
| Q3 2021 | 1,011,000 | 642,000 |
| Q4 2021 | 688,000 | 647,000 |
| Q1 2022 | 159,000 | 208,000 |
| Q2 2022 | 99,000 | 16,000 |
| Q3 2022 | 87,000 | 0 |
| Q4 2022 | 60,000 | 0 |
| Q1 2023 | 1,000 | 0 |